VTX-2337 is a novel TLR8 agonist that activates NK cells and augments ADCC. (Q42723314)
Jump to navigation
Jump to search
scientific article published on 29 November 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | VTX-2337 is a novel TLR8 agonist that activates NK cells and augments ADCC. |
scientific article published on 29 November 2011 |
Statements
1 reference
VTX-2337 is a novel TLR8 agonist that activates NK cells and augments ADCC. (English)
1 reference
Hailing Lu
1 reference
Gregory N Dietsch
1 reference
Maura-Ann H Matthews
1 reference
Yi Yang
1 reference
Smita Ghanekar
1 reference
Margaret Inokuma
1 reference
Maria Suni
1 reference
Vernon C Maino
1 reference
Katherine E Henderson
1 reference
James Jeffry Howbert
1 reference
Mary L Disis
1 reference
Robert M Hershberg
1 reference
29 November 2011
1 reference
1 reference
Identifiers
1 reference